Riskpilot← Back to searchSign inGet full accessApohem AB
ABActiveOrg 5590948401Norra Stationsgatan 99 0trRetail sale of pharmaceutical products · NACE 4773Est. 2016130 employees
Revenue 2024
SEK 892,8M
+41% vs 2023
EBITDA margin
-8.8%
+18% vs 2023
Equity ratio
5.6%
Financial strength
Net profit 2024
SEK -82,9M
+16% vs 2023
| Revenue | SEK 892,8M | +41% |
| EBITDA | SEK -78,8M | +18% |
| Net profit | SEK -82,9M | +16% |
| Total assets | SEK 171,1M | +3% |
| Equity | SEK 9,5M | -85% |
| Employees | 130 | — |
Legal name
Apohem AB
Org number
5590948401
Legal form
Aktiebolag
NACE code
4773 · Retail sale of pharmaceutical products
Founded
29 december 2016
Share capital
SEK 749 000
Employees
130 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas av en av Hedman, Jan Jonas Stenbeck, Carl Johan i förening med en av ledamöterna Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolaget ska bedriva import, export, handel och försäljning av apoteksnära handelsvaror, läkemedel och kringliggande sortiment och därmed förenlig verksamhet.
Address
Norra Stationsgatan 99 0tr
Phone
+46812828600
Email
erik.elveros@apohem.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 6 273 | 39 250 | 140 564 | 244 253 | 423 625 | 632 861 | 892 836 |
| Staff expenses | — | — | — | — | — | — | — | — |
| EBITDA | −4 540 | −35 402 | −48 520 | −76 665 | −78 392 | −108 674 | −96 281 | −78 754 |
| Depreciation & amort. | −0 | −0 | −0 | −137 | −541 | −1 379 | −2 887 | −3 932 |
| EBIT | −4 540 | −35 402 | −48 520 | −76 802 | −78 933 | −110 053 | −99 168 | −82 686 |
| Net financials | — | −8 | −15 | −153 | −140 | −195 | 3 | −183 |
| Profit before tax | −4 540 | −35 409 | −48 535 | −76 955 | −79 073 | −110 247 | −99 165 | −82 870 |
| Tax | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| Net profit | −4 540 | −35 409 | −48 535 | −76 955 | −79 073 | −110 247 | −99 165 | −82 870 |
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| Total assets | 8 982 | 19 719 | 21 012 | 45 094 | 74 301 | 104 996 | 165 485 | 171 113 |
| Equity | 8 018 | 8 552 | 8 560 | 6 606 | 19 532 | 39 396 | 62 407 | 9 539 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 964 | 11 075 | 12 452 | 38 489 | 54 769 | 65 600 | 103 079 | 161 575 |
| Total debt | 964 | 11 075 | 12 452 | 38 489 | 54 769 | 65 600 | 103 079 | 161 575 |
EBITDA margin
-8.8%
This company
15.8%
Market median
-156% vs market
20172024
Equity ratio
5.6%
This company
38.2%
Market median
-85% vs market
20172024
Return on equity
-868.7%
This company
18.4%
Market median
-4821% vs market
20172024
Net profit margin
-9.3%
This company
8.1%
Market median
-215% vs market
20172024
Asset turnover
5.22×
This company
1.12×
Market median
+366% vs market
20172024
Debt / equity
16.94×
This company
0.62×
Market median
-2632% vs market
20172024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2016-12-01 – 2017-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
KE Chief Auditor | Chief Auditor | 2020 | — | — |
GH Chief Executive Officer | Chief Executive Officer | 2020 | — | — |
KJ Deputy Chief Executive Officer | Deputy Chief Executive Officer | 2020 | — | — |
JL Chief Auditor | Chief Auditor | 2023 | — | — |
CD Chief Auditor | Chief Auditor | 2020 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2022 | — | — | |
| Chairman | 2026 | — | — | |
| Chairman | 2020 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2020 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Axfood Investering och Utveckling AB | Company | 52.0% | 52.0% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
AxRetail AB
Apohem AB Board members of Apohem AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Karl Erik Bertil Olin | Chief Auditor | 0 companies |
| Gustav Hasselgren | Chief Executive Officer | 0 companies |
| Karl Johan Bergenheim | Deputy Chief Executive Officer | 0 companies |
| Johan Lars Bertil Hulthin | Chief Auditor | 0 companies |
| Carl Didrik Roos | Chief Auditor | 0 companies |
| Fredrik Anders Joakim Melin | Board of Directors | 0 companies |
| Marina Davarinou | Board of Directors | 0 companies |
| Carl Johan Stenbeck | Chairman | 0 companies |
| Britt Eivor Andersson | Chairman | 0 companies |
| Jan Jonas Hedman | Board of Directors | 0 companies |
| Simone Rebecka Margulies | Board of Directors | 0 companies |
| Emma Magdalena Stjernlöf | Board of Directors | 0 companies |